the october passage of canada’s historic pharmacare bill deserves celebration – but let’s save the real kudos for when pharmacare is a reality for canadians across the country.
getting the bill through the house and the senate was one matter; the government must now get on with the work of finalizing bilateral agreements with provincial and territorial governments so that essential medications included in the bill will reach those who need them, swiftly.
canadians have been waiting long enough: the first phase of the pharmacare needs to be active by april 2025.
the pharmacare bill lays the foundational principles for the first phase of national universal pharmacare through publicly funded coverage of diabetes and contraceptive medications. this is a step in the right direction to improve drug access, affordability, coverage, equity and cost savings to our healthcare system.
pharmacare makes good health and financial sense. not just for diabetes and birth control – but for medications for heart disease and stroke too.
a feasible next step would include adding cardiovascular medications commonly used by people with diabetes, as diabetes is an important risk factor for heart disease and stroke. people with diabetes are more likely to develop heart disease at a younger age and three times more likely to die of it.